Real world safety of bevacizumab in cancer patients: A systematic literature review of case reports.
CONCLUSION: Bevacizumab is associated with more ADRs in the real world among cancer patients than those reported during clinical trials.
PMID: 32444564 [PubMed - as supplied by publisher]
Source: International Journal of Risk and Safety in Medicine - Category: Drugs & Pharmacology Tags: Int J Risk Saf Med Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Clinical Trials | Drugs & Pharmacology | Gastroenterology | Men | Respiratory Medicine